Clinical Trial Update: Bevacizumabe or Triamcinolone for Persistent Diabetic Macular Edema [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on bevacizumab or triamcinolone for persistent diabetic macular edema (Phase 2/Phase 3) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Bevacizumab (bevacizumab)
• Triamcinolone (triamcinolone)

Snippet

Sponsor: University of Sao Paulo | Conditions: Diabetic Macular Edema | Phase 2, Phase 3 | Status: COMPLETED